A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

Exclusion Criteria

• •Co-existing Condition:
• •Patients with the following are excluded:
• •Oral lesions diagnostic of oral candidiasis or systemic candidiasis.
• •Suspected or proven candidal esophagitis.
• •Patients with the following are excluded:
• •Oral lesions diagnostic of oral candidiasis or systemic candidiasis.
• •Receiving any effective antifungal agent orally or intravenously within 72 hours of study entry.
• •Not expected to survive for at least 6 months.
• •Unable to voluntarily maintain a pastille in the buccal cavity for approximately 20 minutes twice a day.
• •Known hypersensitivity to nystatin.
• •Suspected or proven candidal esophagitis.
• •Prior Medication:
• •Excluded within 72 hours of study entry:
• •Any oral or intravenous antifungal agent.